Investor Presentaiton

Research & Development Cumulative R&D Spend of over Rs 130 billion to date . R&D Spend R&D spend at 8.6% of Net Sales for FY18 • Strong cash flows & large scale to support R&D investments Capabilities Organization IPR Support Focus © Sun Pharmaceutical Industries Limited. All Rights Reserved. • Strong research teams in generics, finished dosage development, biological support, chemistry ⚫2,000 scientists globally with capabilities across dosage forms like orals, liquids, ointments, gels, sprays, injectables • Strong team of intellectual property experts supporting R&D (internal and external lawyers) •Developing non infringing formulations and development of specialty/complex products SUN PHARMA 36

View entire presentation